Carlos Baezner

Learn More
BACKGROUND Lymphangioleiomyomatosis (LAM) is a rare lung disease characterised by progressive airflow obstruction. No effective medical treatment is available but therapy with sirolimus has shown some promise. The aim of this observational study was to evaluate sirolimus in progressive LAM. METHODS Sirolimus (trough level 5 - 10 ng/ml) was administered to(More)
  • 1